Used in pharmaceutical research as a key scaffold in the development of anticancer agents. Shows promising activity against tumor cell lines by inhibiting microtubule assembly, similar to combretastatin A-4. Also investigated for antimicrobial properties, particularly against resistant bacterial strains. Its structural features make it suitable for modifying to enhance bioavailability and target specificity in drug design.